Oxaprozin
- Product NDC
- 70332-311
- 11-digit product format
- 703320311
- Labeler code
- 70332
- Product ID
- 70332-311_61cf2924-8dc1-7f5c-e053-2991aa0ac527
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxaprozin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- California Pharmaceutical LLC
- Application
- ANDA208633
- Marketing category
- ANDA
- Marketing start
- 2018-01-02
- Marketing end
- 0000-00-00
- Substance
- OXAPROZIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70332-311-02 | Oxaprozin | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70332-311 | OXAPROZIN TABLET [CALIFORNIA PHARMACEUTICAL LLC] | 1 | Legacy NDC, 1 package rows | 20180104_61cf2924-8dc0-7f5c-e053-2991aa0ac527.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 70332-311-02 | 70332031102 | 60 in 1 BOTTLE | Historical |